Figure 5.
Impact of hematopoietic stem cell transplantation in first complete remission. Four-month landmark analysis for hemtopoietic stem cell transplantation (HSCT) in first complete remisssion (CR1) among patients who achieved remission. (A) Overall survival and (B) cumulative incidence of relapse (CIR). HR: hazard ratio; CI: confidence interval.